Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
1.
Eur J Clin Nutr ; 70(9): 1034-8, 2016 09.
Article in English | MEDLINE | ID: mdl-27329612

ABSTRACT

BACKGROUND/OBJECTIVE: Excessive fructose intake has been linked to hyperuricaemia. Our aim was to test whether 355 and 600 ml of commercial sugar-sweetened soft drinks would acutely raise plasma uric acid. SUBJECTS/METHODS: Forty-one participants were randomised to a control group or an intervention group. The control group consumed 600 ml of fructose and 600 ml of glucose beverages. The soft drink group consumed 355 and 600 ml of beverages in random order. The control beverages were matched for fructose content with 600 ml of soft drink (26.7 g). Blood samples were collected at baseline, 30 and 60 min and analysed for plasma uric acid. RESULTS: Plasma uric acid concentrations were 13 (95% confidence interval: (CI): 3, 23) and 17 µmol/l (95% CI: 6, 28) higher 30 and 60 min after consumption of 600 ml of soft drink compared with the glucose control. The corresponding values for the fructose beverage were 22 (95% CI: 16, 29) and 23 µmol/l (95% CI: 14, 33). There was no significant difference in the increase in uric acid following the 600-ml soft drink compared with the fructose control at 30 min (6 µmol/l; 95% CI: -4, 15) or 60 min (5 µmol/l; 95% CI: -7, 17). There was no difference in the uric-acid-raising effect between the 355 and 600 ml volumes at 30 min (-1 µmol/l; 95% CI: -9, 6) or 60 min (-5 µmol/l; 95% CI: -10, 1). CONCLUSION: Small and transient increases in plasma uric acid are likely after consumption of sucrose-sweetened commercially available single-serve soft drinks in volumes as small as 355 ml.


Subject(s)
Carbonated Beverages , Diet , Dietary Sugars/pharmacology , Feeding Behavior , Fructose/pharmacology , Sweetening Agents/pharmacology , Uric Acid/blood , Adult , Beverages , Female , Glucose/pharmacology , Humans , Male , Sucrose/pharmacology , Young Adult
2.
Diabet Med ; 30(3): e101-7, 2013 Mar.
Article in English | MEDLINE | ID: mdl-23181689

ABSTRACT

AIMS: Diabetes rates are especially high in China. Risk of Type 2 diabetes increases with high intakes of white rice, a staple food of Chinese people. Ethnic differences in postprandial glycaemia have been reported. We compared glycaemic responses to glucose and five rice varieties in people of European and Chinese ethnicity and examined possible determinants of ethnic differences in postprandial glycaemia. METHODS: Self-identified Chinese (n = 32) and European (n = 31) healthy volunteers attended on eight occasions for studies following ingestion of glucose and jasmine, basmati, brown, Doongara(®) and parboiled rice. In addition to measuring glycaemic response, we investigated physical activity levels, extent of chewing of rice and salivary α-amylase activity to determine whether these measures explained any differences in postprandial glycaemia. RESULTS: Glycaemic response, measured by incremental area under the glucose curve, was over 60% greater for the five rice varieties (P < 0.001) and 39% greater for glucose (P < 0.004) amongst Chinese compared with Europeans. The calculated glycaemic index was approximately 20% greater for rice varieties other than basmati (P = 0.01 to 0.05). Ethnicity [adjusted risk ratio 1.4 (1.2-1.8) P < 0.001] and rice variety were the only important determinants of incremental area under the glucose curve. CONCLUSIONS: Glycaemic responses following ingestion of glucose and several rice varieties are appreciably greater in Chinese compared with Europeans, suggesting the need to review recommendations regarding dietary carbohydrate amongst rice-eating populations at high risk of diabetes.


Subject(s)
Asian People/ethnology , Glucose/pharmacology , Glycemic Index/physiology , Oryza , Sweetening Agents/pharmacology , White People/ethnology , Adolescent , Adult , Age Distribution , Area Under Curve , Blood Glucose/metabolism , China/ethnology , Female , Glycemic Index/drug effects , Humans , Male , Middle Aged , New Zealand/epidemiology , Postprandial Period/physiology , Young Adult
3.
Eur J Clin Nutr ; 64(2): 224-6, 2010 Feb.
Article in English | MEDLINE | ID: mdl-19935822

ABSTRACT

A crossover study was designed to determine whether the fat and carbohydrate contents of evening meals consumed the night preceding glycaemic index (GI) testing had an effect on the GI. Twenty participants consumed two different evening meals in which the energy contributions from fat, carbohydrate and protein were in the ratio 50:30:15 and 25:60:15, respectively. Each participant completed eight tests that involved two evening meals with different macronutrient compositions followed the next morning by two treatments, glucose beverage or fruit bread, all carried out in duplicate. The GI of fruit bread was determined on the mornings following each of the evening meals. The GIs (95% CI) were 68 (60, 76) and 59 (52, 67) after the high-carbohydrate and high-fat meals, respectively, and were not different (P=0.11). Thus, varying the fat and carbohydrate contents of the evening meal before GI testing the next morning did not affect the GI.


Subject(s)
Blood Glucose/metabolism , Dietary Carbohydrates/pharmacology , Dietary Fats/pharmacology , Glycemic Index , Adult , Area Under Curve , Cross-Over Studies , Dietary Proteins , Energy Intake , Female , Humans , Male , Time Factors , Young Adult
4.
Eur J Clin Nutr ; 62(3): 373-8, 2008 Mar.
Article in English | MEDLINE | ID: mdl-17342165

ABSTRACT

OBJECTIVE: To describe the vitamin D status of women living in two Asian cities,--Jakarta (6 degrees S) and Kuala-Lumpur (2 degrees N), to examine the association between plasma 25-hydroxyvitamin D and parathyroid hormone (PTH) concentrations, and to determine a threshold for plasma 25-hydroxyvitamin D above which there is no further suppression of PTH. Also, to determine whether dietary calcium intake influences the relationship between PTH and 25-hydroxyvitamin D. DESIGN: Cross-sectional. SETTING: Jakarta, Indonesia and Kuala Lumpur, Malaysia. PARTICIPANTS: A convenience sample of 504 non-pregnant women 18-40 years. MAIN MEASURES: Plasma 25-hydroxyvitamin D and PTH. RESULTS: The mean 25-hydroxyvitamin D concentration was 48 nmol/l. Less than 1% of women had a 25-hydroxyvitamin D concentration indicative of vitamin D deficiency (<17.5 nmol/l); whereas, over 60% of women had a 25-hydroxyvitamin D concentration indicative of insufficiency (<50 nmol/l). We estimate that 52 nmol/l was the threshold concentration for plasma 25-hydroxyvitamin D above which no further suppression of PTH occurred. Below and above this concentration the slopes of the regression lines were -0.18 (different from 0; P=0.003) and -0.01 (P=0.775), respectively. The relation between vitamin D status and parathyroid hormone concentration did not differ between women with low, medium or high calcium intakes (P=0.611); however, even in the highest tertile of calcium intake, mean calcium intake was only 657 mg/d. CONCLUSION: On the basis of maximal suppression of PTH we estimate an optimal 25-hydroxyvitamin D concentration of approximately 50 nmol/l. Many women had a 25-hydroxyvitamin D below this concentration and may benefit from improved vitamin D status.


Subject(s)
Nutritional Status , Parathyroid Hormone/blood , Vitamin D Deficiency/blood , Vitamin D Deficiency/physiopathology , Vitamin D/blood , Adolescent , Adult , Cross-Sectional Studies , Female , Humans , Indonesia , Malaysia , Vitamin D/analogs & derivatives , Women's Health
5.
Eur J Clin Nutr ; 61 Suppl 1: S122-31, 2007 Dec.
Article in English | MEDLINE | ID: mdl-17992183

ABSTRACT

Glycemic index (GI) describes the blood glucose response after consumption of a carbohydrate containing test food relative to a carbohydrate containing reference food, typically glucose or white bread. GI was originally designed for people with diabetes as a guide to food selection, advice being given to select foods with a low GI. The amount of food consumed is a major determinant of postprandial hyperglycemia, and the concept of glycemic load (GL) takes account of the GI of a food and the amount eaten. More recent recommendations regarding the potential of low GI and GL diets to reduce the risk of chronic diseases and to treat conditions other than diabetes, should be interpreted in the light of the individual variation in blood glucose levels and other methodological issues relating to measurement of GI and GL. Several factors explain the large inter- and intra-individual variation in glycemic response to foods. More reliable measurements of GI and GL of individual foods than are currently available can be obtained by studying, under standard conditions, a larger number of subjects than has typically been the case in the past. Meta-analyses suggest that foods with a low GI or GL may confer benefit in terms of glycemic control in diabetes and lipid management. However, low GI and GL foods can be energy dense and contain substantial amounts of sugars or undesirable fats that contribute to a diminished glycemic response. Therefore, functionality in terms of a low glycemic response alone does not necessarily justify a health claim. Most studies, which have demonstrated health benefits of low GI or GL involved naturally occurring and minimally processed carbohydrate containing cereals, vegetables and fruit. These foods have qualities other than their immediate impact on postprandial glycemia as a basis to recommend their consumption. When the GI or GL concepts are used to guide food choice, this should be done in the context of other nutritional indicators and when values have been reliably measured in a large group of individuals.


Subject(s)
Blood Glucose/metabolism , Diabetes Mellitus, Type 2/metabolism , Dietary Carbohydrates/pharmacokinetics , Glycemic Index , Hyperlipidemias/metabolism , Area Under Curve , Diabetes Mellitus, Type 2/diet therapy , Dose-Response Relationship, Drug , Food, Organic , Humans , Hyperlipidemias/diet therapy , Intestinal Absorption/drug effects , Lipid Metabolism/drug effects , Lipid Metabolism/physiology , Nutritive Value , Postprandial Period , Satiation/drug effects
6.
Atherosclerosis ; 188(1): 175-8, 2006 Sep.
Article in English | MEDLINE | ID: mdl-16298373

ABSTRACT

Beta-casein is a cow's milk protein that occurs predominantly in two forms, A1 and A2. Epidemiological evidence suggests that per capita consumption of beta-casein A1 is associated with national mortality rates from ischaemic heart disease. A biological mechanism was proposed after rabbits fed diets containing beta-casein A2 had lower serum cholesterol concentrations and less aortic intimal thickening than rabbits fed beta-casein A1. We tested whether beta-casein A1 and A2 variants differentially affect plasma cholesterol concentrations in humans. In a randomised crossover trial of two four-and-a-half week periods without washout, 62 participants replaced all dairy products in their diet with 500 mL of low-fat milk and 28 g of full-fat cheese that differed in the proportion of beta-casein A1 and A2 variants. Duplicate blood samples were taken on non-consecutive days at the end of each treatment period from 55 people who completed the study. Mean (S.D.) plasma total, low-density and high-density lipoprotein cholesterol concentrations were 5.60 (0.77), 3.73 (0.70) and 1.26 (0.34) mmol/L after the A1 diet and 5.63 (0.81), 3.75 (0.75) and 1.27 (0.37) mmol/L after the A2 diets. We found no evidence that dairy products containing beta-casein A1 or A2 exerted differential effects (P > 0.05) on plasma cholesterol concentrations in humans.


Subject(s)
Caseins/administration & dosage , Cholesterol, HDL/blood , Cholesterol, LDL/blood , Diet, Atherogenic , Dietary Proteins/administration & dosage , Milk Proteins/administration & dosage , Adult , Aged , Animals , Caseins/analysis , Dietary Proteins/analysis , Female , Humans , Middle Aged , Milk/chemistry , Milk Proteins/analysis , New Zealand
7.
Eur J Clin Nutr ; 59(2): 205-10, 2005 Feb.
Article in English | MEDLINE | ID: mdl-15483636

ABSTRACT

OBJECTIVE: To determine the serum vitamin B(12) status of older New Zealanders and to assess the impact of atrophic gastritis on vitamin B(12) status. DESIGN: A cross-sectional nationally representative population-based survey. METHOD: Serum vitamin B(12) concentrations were used to assess vitamin B(12) status. The presence and severity of atrophic gastritis was classified using serum pepsinogen I and II. SUBJECTS: A total of 466 noninstitutionalized urban and rural dwelling New Zealanders aged 65 y or older who participated in the 1997 National Nutrition Survey. RESULTS: The prevalence of deficient (<148 pmol/l) and marginal (148-221 pmol/l) serum vitamin B(12) concentrations was 12 and 28%, respectively. The prevalence of atrophic gastritis was 6.7% (severe 3.1%, mild-moderate 3.6%). While atrophic gastritis increased the relative risk (RR, 95% CI) of having a deficient or marginal serum vitamin B(12) concentration by 21-fold (6-67) and five-fold (1-17), respectively, those who had atrophic gastritis made up only 33 and 6% of the participants with deficient or marginal serum vitamin B(12) concentrations. An intake of vitamin B(12) from food that exceeded the recommended dietary allowance (2.4 mug/day) did not protect against deficient (RR 0.5; 95% CI: 0.2, 1.2) or marginal (RR 0.9; 95% CI: 0.5, 1.7) serum vitamin B(12) status. Vitamin B(12) supplement users had a reduced risk of having deficient and marginal vitamin B(12) status (RR 0.3; 95% CI: 0.1, 0.8). CONCLUSIONS: There is a relatively high prevalence of deficient and marginal serum vitamin B(12) concentrations among older New Zealanders. However, the prevalence of atrophic gastritis was low in the New Zealand elderly compared with other surveys. Although atrophic gastritis was a risk factor for low vitamin B(12) status, it did not fully explain the prevalence of low serum vitamin B(12).


Subject(s)
Gastritis, Atrophic/blood , Vitamin B 12 Deficiency/blood , Vitamin B 12/administration & dosage , Vitamin B 12/blood , Aged , Confidence Intervals , Cross-Sectional Studies , Female , Gastritis, Atrophic/epidemiology , Humans , Male , New Zealand/epidemiology , Nutrition Surveys , Risk , Rural Population , Seroepidemiologic Studies , Urban Population , Vitamin B 12 Deficiency/epidemiology
8.
Eur J Clin Nutr ; 58(11): 1443-61, 2004 Nov.
Article in English | MEDLINE | ID: mdl-15162131

ABSTRACT

This review examines the evidence for the role of whole grain foods and legumes in the aetiology and management of diabetes. MedLine and SilverPlatter ('Nutrition' and 'Food Science FSTA') databases were searched to identify epidemiological and experimental studies relating to the effects of whole grain foods and legumes on indicators of carbohydrate metabolism. Epidemiological studies strongly support the suggestion that high intakes of whole grain foods protect against the development of type II diabetes mellitus (T2DM). People who consume approximately 3 servings per day of whole grain foods are less likely to develop T2DM than low consumers (<3 servings per week) with a risk reduction in the order of 20-30%. The role of legumes in the prevention of diabetes is less clear, possibly because of the relatively low intake of leguminous foods in the populations studied. However, legumes share several qualities with whole grains of potential benefit to glycaemic control including slow release carbohydrate and a high fibre content. A substantial increase in dietary intake of legumes as replacement food for more rapidly digested carbohydrate might therefore be expected to improve glycaemic control and thus reduce incident diabetes. This is consistent with the results of dietary intervention studies that have found improvements in glycaemic control after increasing the dietary intake of whole grain foods, legumes, vegetables and fruit. The benefit has been attributed to an increase in soluble fibre intake. However, prospective studies have found that soluble fibre intake is not associated with a lower incidence of T2DM. On the contrary, it is cereal fibre that is largely insoluble that is associated with a reduced risk of developing T2DM. Despite this, the addition of wheat bran to the diets of diabetic people has not improved indicators of glycaemic control. These apparently contradictory findings might be explained by metabolic studies that have indicated improvement in glucose handling is associated with the intact structure of food. For both grains and legumes, fine grinding disrupts cell structures and renders starch more readily accessible for digestion. The extent to which the intact structure of grains and legumes or the composition of foods in terms of dietary fibre and other constituents contribute to the beneficial effect remains to be quantified. Other mechanisms to help explain improvements in glycaemic control when consuming whole grains and legumes relate to cooking, type of starch, satiety and nutrient retention. Thus, there is strong evidence to suggest that eating a variety of whole grain foods and legumes is beneficial in the prevention and management of diabetes. This is compatible with advice from around the world that recommends consumption of a wide range of carbohydrate foods from cereals, vegetables, legumes and fruits both for the general population and for people with diabetes.


Subject(s)
Diabetes Mellitus, Type 2/etiology , Diabetes Mellitus, Type 2/prevention & control , Dietary Fiber/administration & dosage , Edible Grain , Fabaceae , Blood Glucose/drug effects , Blood Glucose/metabolism , Diabetes Mellitus, Type 2/epidemiology , Dietary Fiber/metabolism , Edible Grain/chemistry , Epidemiologic Studies , Fabaceae/chemistry , Fruit , Humans , Prospective Studies , Risk Factors , Solubility , Vegetables
9.
Eur J Clin Nutr ; 56(8): 748-54, 2002 Aug.
Article in English | MEDLINE | ID: mdl-12122551

ABSTRACT

OBJECTIVE: To determine the minimum effective dose of folic acid required to appreciably increase serum folate and to produce a significant reduction in plasma total homocysteine (tHcy). DESIGN: Double-blind, randomised placebo-controlled intervention trial. SETTING: Community-based project in a New Zealand city. SUBJECTS: Seventy free living men and women with tHcy> or =10 micromol/l. Mean age (range) was 58 (29-90) y. INTERVENTIONS: Daily consumption over 4 weeks of 20 g breakfast cereal either unfortified (placebo) or fortified with 100, 200 or 300 microg folic acid. Dietary intake was determined by weighed diet records and consumption of commercially fortified products was avoided. MAIN OUTCOME MEASURES: Plasma tHcy and serum folate concentrations. RESULTS: Average serum folate concentrations (95% CI) increased significantly in the treatment groups relative to the control group by 28(9-51)%, 60(37-87)% and 79(51-114)% for supplementation with 100, 200 and 300 microg folic acid, respectively. A reduction in tHcy was observed, being 16(8-22)%, 12(4-18)% and 17(9-24)% in the three treatment groups, respectively. CONCLUSIONS: A regular intake of as little as 100 microg folic acid per day was sufficient to lower tHcy in persons at the upper end of the normal range for tHcy. Low-level fortification may also be appropriate for lowering the risk of neural tube defects given that, when aggregated from all sources, the total intake of folic acid may be sufficiently high to adequately improve the folate status of young women.


Subject(s)
Folic Acid/administration & dosage , Folic Acid/blood , Homocysteine/blood , Adult , Aged , Aged, 80 and over , Dose-Response Relationship, Drug , Double-Blind Method , Edible Grain , Female , Food, Fortified , Humans , Hyperhomocysteinemia/therapy , Male , Middle Aged , Neural Tube Defects/prevention & control , Nutritional Requirements , Placebos , Vitamin B 12/blood
SELECTION OF CITATIONS
SEARCH DETAIL
...